Voyager Therapeutics

-$0.18 (-5.45%) Today

$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYGR and other ETFs, options, and stocks.

About VYGR

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01.

CEO

Michael J. Higgins

Employees

179

Headquarters

Cambridge, Massachusetts

Founded

2013

VYGR Key Statistics

Market Cap

157.29M

Price-Earnings Ratio

3.19

Dividend Yield

—

Average Volume

311.39K

High Today

$3.30

Low Today

$3.10

Open Price

$3.30

Volume

629.59K

52 Week High

$12.70

52 Week Low

$3.10

Analyst Ratings

64%

of 11 ratings

Buy

36.4%

Hold

63.6%

Sell

VYGR Earnings

-$0.81

$0.22

$1.24

$2.27

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 9, Pre-Market